Pluri Expects 50% Stake in ZEO ScientifiX Under Strategic Agreement
- Pluri expects to hold 50% of ZEO ScientifiX under a signed strategic agreement, subject to closing and transaction terms.
- The deal targets expansion into the US regenerative medicine market through ZEO's Florida biologics operations, marketed products and physician relationships.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pluri Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611160800PRIMZONEFULLFEED9878239) on November 16, 2026, and is solely responsible for the information contained therein.